February 25, 2002
6:51 PM Subscribe
The NIH is abandoning phase III trials of a possible hiv vaccine due to "technical reasons" the trial will continue in thailand. On a happier note there are currently more than 90 other hiv vaccines in other stages of trials. What do people think are the chances the pharmaceuticals will decide chronic disease management is more profitable, and actually do something to make this a more likely outcome?
This thread has been archived and is closed to new comments